retatrutide type 2 diabetes phase 2 results 2024 ada shows substantial weight loss, glycemic control in obesity and | 2026 The Effect of Retatrutide on

Both Semaglutide and Tirzepatide can be effective options for improving blood sugar control and promoting weight loss

Participants received orforglipron at doses of 6, 12, or 36 mg (which correspond to the current 5.5, 14.5, and 17.2 mg maintenance doses) or placebo, alongside diet and exercise counselling, for 72 weeks

Sleep and stress management Cortisol, the primary stress hormone, directly opposes the metabolic benefits of semaglutide

[18] [19] Gradually reintroducing dietary fibre as tolerated, maintaining adequate fluid intake, and staying physically active can all help

At the same time, there are potential downsides with these medications, such as high cost, side effects, and questions about long-term use